| abstract |
FIELD: medicine; pharmaceuticals.SUBSTANCE: group of inventions relates to the field of medicine and pharmaceuticals. Object 1 is an aqueous suspension for the treatment or prevention of an inflammatory or infectious disease containing nanoparticles of a glucocorticosteroid compound, a physiologically acceptable salt, glycerin, hydrogenated soy lecithin, and anhydrous citric acid. Objects 2 and 3 are the corresponding pharmaceutical composition and a set for obtaining a pharmaceutical composition. Object 4 is a method for making a pharmaceutical composition, including mixing a glucocorticosteroid compound, a physiologically acceptable salt, glycerol, hydrogenated soy lecithin, anhydrous citric acid and water.EFFECT: stability of the storage properties and the stability of the dispersion of the suspension and pharmaceutical composition containing nanoparticles of a low-size glucocorticosteroid compound as the active component, due to the use of nanoparticles of a glucocorticosteroid compound, a physiologically acceptable salt, glycerol, hydrogenated soy lecithin and anhydrous citric acid.21 cl, 13 dwg, 11 tbl, 13 ex |